Clinical Trial Update: Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating best available therapy with or without meropenem for bloodstream infections caused by carbapenem-resistant Enterobacterales; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infection
• Carbapenem-resistant Enterobacteriaceae Infection

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection | Phase 2, Phase 3 | Status: TERMINATED